A detailed history of Gables Capital Management Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Gables Capital Management Inc. holds 200 shares of TEVA stock, worth $3,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$3,690
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$8.57 - $12.69 $25,710 - $38,070
-3,000 Reduced 93.75%
200 $2,000
Q1 2020

May 07, 2020

BUY
$6.69 - $13.45 $20,070 - $40,350
3,000 Added 1500.0%
3,200 $29,000
Q2 2018

Aug 03, 2018

BUY
$16.77 - $24.71 $3,354 - $4,942
200 New
200 $5,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Gables Capital Management Inc. Portfolio

Follow Gables Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gables Capital Management Inc. with notifications on news.